In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
skip over navigation
Print
PRINT  
Email
EMAIL

Cancer

 Lymphoma, Leukemia, and Myeloma

Learn More

Dotted Line

MoreMedical

Simmons Center earns National Cancer Institute designation

MoreScience

Researchers find way to help donor adult blood stem cells overcome transplant rejection

UTSW participates in study offering free lung tumor genetic testing

Researchers find key step in body's ability to make red blood cells

Cancers of the blood, bone marrow or lymph nodes are known as hematologic malignancies. Through recent extensive research, researchers now know that there are many more subtypes of these diseases than was previously believed. Each of these subtypes requires its own particular therapy, which is why it is so critical to accurately diagnose the subtype of lymphoma, leukemia, myeloma or myelodysplastic syndromes (MDS).

Correct treatment depends on the precise diagnosis and particular characteristics of the patient, such as age, general health and genetics. Treatments include mild oral chemotherapy, more aggressive intravenous chemotherapy, immunotherapy, radiation, stem-cell or bone-marrow transplantation and experimental therapy. In some patients with very mild and slow-growing disease, a period of close observation is considered to be appropriate.

UT Southwestern Medical Center’s physicians and researchers have access to the latest scientific findings and treatments for hematological cancers, including:

  • Lymphoma, including Hodgkin's disease and the non-Hodgkin's lymphomas
  • Leukemia
  • Myeloma
  • Bone marrow transplant
  • Myelodysplastic syndrome

Please visit the Health Library to learn more about lymphoma, leukemia and myeloma.

Drop Shadow